Patent · US Expired

Anti-factor IX/IXa antibodies

US6391299B1 · kind B1 · utility

19Cited by
1References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 25, 1999
Grant dateMay 21, 2002
Priority date
Expiry dateJun 25, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies directed against coagulation factors and their use in inhibiting thrombosis are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.